Dear Reader

FDA Approves VELCADE® for the Treatment of Relapsed and Refractory Multiple Myeloma

Profile Interview: Julian Adams, Ph.D.

Life Lessons from a Politician

Myeloma Update: Overview of the 9th International Workshop on Multiple Myeloma International Prognostic Index, and Bank On a Cure

Letters

Q&A: Get Your Questions Answered

News & Notes

2003 IMF Anniversary Gala 

Click here to download Myeloma Today